{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:44:30Z","timestamp":1770975870358,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.rmcr.2025.102330","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:16:20Z","timestamp":1764173780000},"page":"102330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metastatic lung pleomorphic giant cell carcinoma treated with multimodality systemic anti-cancer treatment, a two-year journey: A case report"],"prefix":"10.1016","volume":"58","author":[{"given":"Aladdin","family":"Kanbour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-5158","authenticated-orcid":false,"given":"Mohannad N.","family":"AbuHaweeleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Al-Bozom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bara","family":"Wazwaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athar","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razhan","family":"Madhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harman","family":"Saman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2025.102330_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.humpath.2015.10.006","article-title":"Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies","volume":"49","author":"Forest","year":"2016","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.rmcr.2025.102330_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180346","article-title":"PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis","volume":"12","author":"Yvorel","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.rmcr.2025.102330_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0873-2159(15)30258-0","article-title":"[Primary pleomorphic sarcoma of the lung]","volume":"14","author":"da Matta Abreu","year":"2008","journal-title":"Rev. Port. Pneumol."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102330_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.rmcr.2025.102330_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2014.11.007","article-title":"Clinicopathological analysis of pleomorphic carcinoma of the lung: diffuse ZEB1 expression predicts poor survival","volume":"87","author":"Miyahara","year":"2015","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.rmcr.2025.102330_bib7","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/PAS.0b013e3181804302","article-title":"Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases","volume":"32","author":"Mochizuki","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.rmcr.2025.102330_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biopha.2015.10.009","article-title":"Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma","volume":"76","author":"Gu","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.rmcr.2025.102330_bib9","article-title":"Pulmonary pleomorphic carcinoma presenting as undifferentiated non-small cell carcinoma with giant cells: a case report and review of literature","volume":"31","author":"Jeong","year":"2020","journal-title":"Respir. Med. Case Rep."},{"issue":"29","key":"10.1016\/j.rmcr.2025.102330_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007465","article-title":"Pulmonary pleomorphic carcinoma: a case report and review of the literature","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.rmcr.2025.102330_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.semdp.2021.09.003","article-title":"Pleomorphic (giant cell) carcinoma revisited: a historical perspective and conceptual reappraisal","volume":"38","author":"Agaimy","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102330_bib12","first-page":"183","article-title":"[Clinicopathologic features of lung pleomorphic (spindle\/giant cell) carcinoma--a report of 17 cases]","volume":"26","author":"Zhao","year":"2007","journal-title":"Ai Zheng"},{"issue":"5","key":"10.1016\/j.rmcr.2025.102330_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cllc.2016.03.001","article-title":"Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung","volume":"17","author":"Ung","year":"2016","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.rmcr.2025.102330_bib14","article-title":"Characteristics and prognostic analysis of 55 patients with pulmonary sarcomatoid carcinoma","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.rmcr.2025.102330_bib15","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U","article-title":"Pleomorphic (spindle\/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases","volume":"73","author":"Fishback","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.rmcr.2025.102330_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<608::AID-CNCR9>3.0.CO;2-1","article-title":"Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases","volume":"86","author":"Nakajima","year":"1999","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.rmcr.2025.102330_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/00000478-199912000-00009","article-title":"Carcinosarcomas of the lung: a clinicopathologic study of 66 patients","volume":"23","author":"Koss","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.rmcr.2025.102330_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.21147\/j.issn.1000-9604.2016.05.03","article-title":"Further understanding of an uncommon disease of combined small cell lung cancer: clinical features and prognostic factors of 114 cases","volume":"28","author":"Men","year":"2016","journal-title":"Chin. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/ajco.13460","article-title":"Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma","volume":"17","author":"Agackiran","year":"2021","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.rmcr.2025.102330_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2007.05.006","article-title":"Palliative chemotherapy for pulmonary pleomorphic carcinoma","volume":"58","author":"Bae","year":"2007","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jjco\/hyq180","article-title":"Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy","volume":"41","author":"Lee","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.rmcr.2025.102330_bib22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/PAS.0000000000001112","article-title":"Prostatic adenocarcinoma with focal pleomorphic giant cell features: a series of 30 cases","volume":"42","author":"Alharbi","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/COC.0000000000000101","article-title":"Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma","volume":"39","author":"Lin","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.rmcr.2025.102330_bib24","series-title":"NCCN Clinical Practice Guidelines in Oncology for Non-small Cell Lung Cancer","year":"2025"},{"key":"10.1016\/j.rmcr.2025.102330_bib25","series-title":"Early and Locally Advanced non-small-cell Lung Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and follow-up","author":"Zer","year":"2025"},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib26","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.21873\/invivo.12428","article-title":"Case series of pleomorphic carcinoma of the lung treated with immune checkpoint inhibitors","volume":"35","author":"Hayashi","year":"2021","journal-title":"In Vivo"},{"issue":"7","key":"10.1016\/j.rmcr.2025.102330_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2169\/internalmedicine.1462-18","article-title":"A high PD-L1 expression in pulmonary pleomorphic carcinoma correlates with parietal-pleural invasion and might predict a poor prognosis","volume":"58","author":"Naito","year":"2019","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2025.102330_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3904\/kjim.2017.245","article-title":"Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma","volume":"33","author":"Sim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.rmcr.2025.102330_bib29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s13104-015-1762-z","article-title":"Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma","volume":"8","author":"Tamura","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.rmcr.2025.102330_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221133889","article-title":"Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and\/or giant cell carcinoma","volume":"14","author":"Chang","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.rmcr.2025.102330_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12890-022-01915-1","article-title":"Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102330_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/1759-7714.12086","article-title":"Surgical treatment for pulmonary pleomorphic carcinoma: a retrospective study of 60 patients","volume":"5","author":"Ji","year":"2014","journal-title":"Thorac. Cancer"},{"issue":"2","key":"10.1016\/j.rmcr.2025.102330_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atssr.2023.12.025","article-title":"Pleomorphic carcinoma arising at previous resection margins of ground-glass opacities","volume":"2","author":"Kinno","year":"2024","journal-title":"Ann. Thorac. Surg. Short Rep."},{"issue":"7","key":"10.1016\/j.rmcr.2025.102330_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/JTO.0b013e31817c925c","article-title":"Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma","volume":"3","author":"Aokage","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102330_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtcvs.2007.04.018","article-title":"Pleomorphic carcinoma of the lung: a surgical outcome","volume":"134","author":"Yuki","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:41:48Z","timestamp":1770972108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"alternative-id":["S2213007125001662"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102330","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastatic lung pleomorphic giant cell carcinoma treated with multimodality systemic anti-cancer treatment, a two-year journey: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102330"}}